Another recent attempt at PD-1 blockade was demonstrated by Zhu and colleagues, wherein the glioma vaccine called STDENVANT consisted of glioma stem-like cell (GSC) lysate, DCs, and TLR9 agonists, CpG ODNs. This evidence concerns the gene TLR9 and glioma.